← Eichor
Study identifier: NCT07363278 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Prospective Observational Study Evaluating the Incidence of Silent Cerebral Lesions and Procedural Safety Following Atrial Fibrillation Ablation Using the VARIPULSE™ Pulsed Field Ablation System

Condition: Atrial Fibrillation (AF)  ·  Sponsor: Seoul National University Hospital

PhaseN/A
Planned participants40
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

Study Type: Observational Study Goal: The goal of this study is to evaluate the incidence and burden of silent cerebral lesions (SCLs) detected on brain magnetic resonance imaging (MRI) after pulsed field ablation (PFA) for atrial fibrillation (AF). PFA is a new non-thermal ablation technique that selectively targets cardiac tissue while minimizing damage to surrounding structures. The study focuses on adult patients with paroxysmal or persistent AF who undergo left-atrial ablation using the VARIPULSE PFA system.

This description comes directly from the study's public registry record.

Talk to the study team

Eue-Keun Choi, MD, PhD  ·  82-2-2072-0688  ·  choiek417@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Seoul National Universtiy Hospital, SeoulSeoul, Jongro-ku, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07363278